[HTML][HTML] Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging

I Lopes Alves, F Heeman, LE Collij, G Salvadó… - Alzheimer's Research & …, 2021 - Springer
Background Detecting subtle-to-moderate biomarker changes such as those in amyloid PET
imaging becomes increasingly relevant in the context of primary and secondary prevention …

Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging.

I Lopes Alves, F Heeman, LE Collij… - Alzheimer's …, 2021 - search.ebscohost.com
Background: Detecting subtle-to-moderate biomarker changes such as those in amyloid
PET imaging becomes increasingly relevant in the context of primary and secondary …

[PDF][PDF] Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging

IL Alves, F Heeman, LE Collij, G Salvadó, N Tolboom… - 2021 - amypad.eu
Background: Detecting subtle-to-moderate biomarker changes such as those in amyloid
PET imaging becomes increasingly relevant in the context of primary and secondary …

[PDF][PDF] Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging

IL Alves, F Heeman, LE Collij, G Salvadó, N Tolboom… - 2021 - scholar.archive.org
Background: Detecting subtle-to-moderate biomarker changes such as those in amyloid
PET imaging becomes increasingly relevant in the context of primary and secondary …

[HTML][HTML] Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging

IL Alves, F Heeman, LE Collij, G Salvadó… - … Research & Therapy, 2021 - ncbi.nlm.nih.gov
Background Detecting subtle-to-moderate biomarker changes such as those in amyloid PET
imaging becomes increasingly relevant in the context of primary and secondary prevention …

Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging

I Lopes Alves, F Heeman, LE Collij, G Salvadó… - 2021 - repositori.upf.edu
Background: Detecting subtle-to-moderate biomarker changes such as those in amyloid
PET imaging becomes increasingly relevant in the context of primary and secondary …

Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging

IL Alves, F Heeman, LE Collij… - Alzheimer's …, 2021 - portal.research.lu.se
Background: Detecting subtle-to-moderate biomarker changes such as those in amyloid
PET imaging becomes increasingly relevant in the context of primary and secondary …

[PDF][PDF] Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging

IL Alves, F Heeman, LE Collij, G Salvadó, N Tolboom… - 2021 - researchgate.net
Background: Detecting subtle-to-moderate biomarker changes such as those in amyloid
PET imaging becomes increasingly relevant in the context of primary and secondary …

Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging

IL Alves, F Heeman, LE Collij… - … research & therapy, 2021 - pubmed.ncbi.nlm.nih.gov
Background Detecting subtle-to-moderate biomarker changes such as those in amyloid PET
imaging becomes increasingly relevant in the context of primary and secondary prevention …

[PDF][PDF] Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging

IL Alves, F Heeman, LE Collij, G Salvadó, N Tolboom… - 2021 - pure.eur.nl
Background: Detecting subtle-to-moderate biomarker changes such as those in amyloid
PET imaging becomes increasingly relevant in the context of primary and secondary …